Results 21 to 30 of about 10,072 (202)
A conservative treatment for eosinophilic cystitis
IJU Case Reports, Volume 6, Issue 1, Page 8-12, January 2023., 2023 Introduction Eosinophilic cystitis is a rare condition which causes common symptoms and may mimic other conditions. Eosinophilic cystitis has several causes such as hypereosinophilic syndrome, inflammatory diseases, neoplasia, parasites or fungal infection, IgE‐related diseases, Drug Reaction and Eosinophilia and Systemic Symptoms (DRESS) syndrome, or ...
Franco Alchiede Simonato +6 more
wiley +1 more source
Long-term management of a cat with nasopharyngeal lymphoma by chlorambucil [PDF]
Open Veterinary Journal, 2021 Background: Lymphoma in the nasal cavity is the most common tumor of cats' upper respiratory tract. However, the effect of single-agent chlorambucil on nasal or nasopharyngeal lymphoma has not been evaluated in cats.
Kaho Takahashi +7 more
doaj +1 more source
Dynamic responsiveness of self‐assembling peptide‐based nano‐drug systems
Interdisciplinary Medicine, Volume 1, Issue 1, January 2023., 2023 This review discusses dynamically responsive self‐assembling peptide‐based nano‐drug systems, including the stimulation response, strategy of biomimicry, subcellular internalization, and the applications of peptide nano‐drug materials, and concludes with a brief outlook of their challenges and opportunities in clinical translation.
Yuhan Wang +6 more
wiley +1 more source
Nasal Lymphoma with Low Mitotic Index in Three Cats Treated with Chlorambucil and Prednisolone
Veterinary Sciences, 2022 Lymphoma is the most common tumor of the nasal cavity in cats. Commonly used treatment modalities are radiotherapy and chemotherapy, or both. Typical chemotherapy protocols used in cats with nasal lymphoma are COP (cyclophosphamide, vincristine ...
Karen W. L. Ng +3 more
doaj +1 more source
Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
Pharmaceutics, 2023 In this study, the authors have designed biocompatible nano-vesicles using graphene oxide (GO) for the release of chlorambucil (CHL) drugs targeting cancerous cells.
Surabhi Kumari +7 more
doaj +1 more source
Effect of Statins in the Watch and Wait Phase of Chronic Lymphocytic Leukemia. [PDF]
Cancer MedABSTRACT Background It is an unclear how cholesterol‐lowering statin drugs affect progression of chronic lymphocytic leukemia (CLL). Methods Clinical records of 57 CLL patients were examined to determine how initiating statins in the “watch and wait” phase of management affected disease progression.
Spaner DE.
europepmc +2 more sources
BMC Cancer, 2022 Background Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in North America. Previous studies have shown improved progression free survival (PFS) and response rates in unfit patients treated with obinutuzumab compared to other ...
Nicole Bourrier +11 more
doaj +1 more source
Frontiers in Veterinary Science, 2022 A 7-year-old castrated male Poodle dog presented with chronic progressive lymphocytosis. Hematologic and peripheral blood smear findings included remarkable lymphocytosis with well-differentiated small lymphocytes. Cytology of bone marrow aspirate showed
Ga-Won Lee +6 more
doaj +1 more source
Cytotoxicity of chlorambucil immobilized on magnetic iron oxide nanoparticles Fe3O4
Micro & Nano Letters, 2021 Chlorambucil is a nitrogen mustard alkylating agent used for the treatment of various malignant and non‐malignant cancers. The use of the chemotherapeutic is limited by its toxic side effects which precludes the use of optimal doses.
Julia Nowak‐Jary +2 more
doaj +1 more source
Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
Frontiers in Pharmacology, 2023 Introduction: Development of Poly (ADP-ribose) polymerase (PARP) inhibitors has been extensively studied in cancer treatment. Olaparib, the first approved PARP inhibitor, showed potency in the inhibition of both BRCA (breast cancer associated)-mutated ...
Hongyu Qin +5 more
doaj +1 more source